United States Glaucoma Therapeutics Market Report 2017

United States Glaucoma Therapeutics Market Report 2017

1 Glaucoma Therapeutics Overview

1.1 Product Overview and Scope of Glaucoma Therapeutics

1.2 Classification of Glaucoma Therapeutics by Product Category

1.2.1 United States Glaucoma Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Glaucoma Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Prostaglandins

1.2.4 Alpha Agonist

1.2.5 Beta Blockers

1.2.6 Carbonic Anhydrase Inhibitor

1.2.7 Cholinergic

1.2.8 Combined Medication

1.3 United States Glaucoma Therapeutics Market by Application/End Users

1.3.1 United States Glaucoma Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospitals

1.3.3 Ophthalmic Clinics

1.3.4 Ambulatory Surgical Centers

1.4 United States Glaucoma Therapeutics Market by Region

1.4.1 United States Glaucoma Therapeutics Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Glaucoma Therapeutics Status and Prospect (2012-2022)

1.4.3 Southwest Glaucoma Therapeutics Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Glaucoma Therapeutics Status and Prospect (2012-2022)

1.4.5 New England Glaucoma Therapeutics Status and Prospect (2012-2022)

1.4.6 The South Glaucoma Therapeutics Status and Prospect (2012-2022)

1.4.7 The Midwest Glaucoma Therapeutics Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Glaucoma Therapeutics (2012-2022)

1.5.1 United States Glaucoma Therapeutics Sales and Growth Rate (2012-2022)

1.5.2 United States Glaucoma Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Glaucoma Therapeutics Market Competition by Players/Suppliers

2.1 United States Glaucoma Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Glaucoma Therapeutics Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Glaucoma Therapeutics Average Price by Players/Suppliers (2012-2017)

2.4 United States Glaucoma Therapeutics Market Competitive Situation and Trends

2.4.1 United States Glaucoma Therapeutics Market Concentration Rate

2.4.2 United States Glaucoma Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Glaucoma Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Glaucoma Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Glaucoma Therapeutics Sales and Market Share by Region (2012-2017)

3.2 United States Glaucoma Therapeutics Revenue and Market Share by Region (2012-2017)

3.3 United States Glaucoma Therapeutics Price by Region (2012-2017)

4 United States Glaucoma Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Glaucoma Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Glaucoma Therapeutics Revenue and Market Share by Type (2012-2017)

4.3 United States Glaucoma Therapeutics Price by Type (2012-2017)

4.4 United States Glaucoma Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Glaucoma Therapeutics Sales (Volume) by Application (2012-2017)

5.1 United States Glaucoma Therapeutics Sales and Market Share by Application (2012-2017)

5.2 United States Glaucoma Therapeutics Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Glaucoma Therapeutics Players/Suppliers Profiles and Sales Data

6.1 Allergan

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Glaucoma Therapeutics Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Allergan Glaucoma Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Merck

6.2.2 Glaucoma Therapeutics Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Merck Glaucoma Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Novartis

6.3.2 Glaucoma Therapeutics Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Novartis Glaucoma Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Pfizer

6.4.2 Glaucoma Therapeutics Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Pfizer Glaucoma Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Santen Pharmaceuticals

6.5.2 Glaucoma Therapeutics Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Santen Pharmaceuticals Glaucoma Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Valeant Pharmaceuticals

6.6.2 Glaucoma Therapeutics Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Valeant Pharmaceuticals Glaucoma Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Aerie Pharmaceuticals

6.7.2 Glaucoma Therapeutics Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Aerie Pharmaceuticals Glaucoma Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

...

7 Glaucoma Therapeutics Manufacturing Cost Analysis

7.1 Glaucoma Therapeutics Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Glaucoma Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Glaucoma Therapeutics Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Glaucoma Therapeutics Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Glaucoma Therapeutics Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Glaucoma Therapeutics Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Glaucoma Therapeutics Sales Volume Forecast by Type (2017-2022)

11.3 United States Glaucoma Therapeutics Sales Volume Forecast by Application (2017-2022)

11.4 United States Glaucoma Therapeutics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Glaucoma Therapeutics

Figure United States Glaucoma Therapeutics Market Size (K Pcs) by Type (2012-2022)

Figure United States Glaucoma Therapeutics Sales Volume Market Share by Type (Product Category) in 2016

Figure Prostaglandins Product Picture

Figure Alpha Agonist Product Picture

Figure Beta Blockers Product Picture

Figure Carbonic Anhydrase Inhibitor Product Picture

Figure Cholinergic Product Picture

Figure Combined Medication Product Picture

Figure United States Glaucoma Therapeutics Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Glaucoma Therapeutics by Application in 2016

Figure Hospitals Examples

Figure Ophthalmic Clinics Examples

Figure Ambulatory Surgical Centers Examples

Figure United States Glaucoma Therapeutics Market Size (Million USD) by Region (2012-2022)

Figure The West Glaucoma Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Glaucoma Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Glaucoma Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Glaucoma Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Glaucoma Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Glaucoma Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Glaucoma Therapeutics Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Glaucoma Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Glaucoma Therapeutics Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Glaucoma Therapeutics Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Glaucoma Therapeutics Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Glaucoma Therapeutics Sales Share by Players/Suppliers

Figure 2017 United States Glaucoma Therapeutics Sales Share by Players/Suppliers

Figure United States Glaucoma Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Glaucoma Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Glaucoma Therapeutics Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Glaucoma Therapeutics Revenue Share by Players/Suppliers

Figure 2017 United States Glaucoma Therapeutics Revenue Share by Players/Suppliers

Table United States Market Glaucoma Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Glaucoma Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Glaucoma Therapeutics Market Share of Top 3 Players/Suppliers

Figure United States Glaucoma Therapeutics Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Glaucoma Therapeutics Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Glaucoma Therapeutics Product Category

Table United States Glaucoma Therapeutics Sales (K Pcs) by Region (2012-2017)

Table United States Glaucoma Therapeutics Sales Share by Region (2012-2017)

Figure United States Glaucoma Therapeutics Sales Share by Region (2012-2017)

Figure United States Glaucoma Therapeutics Sales Market Share by Region in 2016

Table United States Glaucoma Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Glaucoma Therapeutics Revenue Share by Region (2012-2017)

Figure United States Glaucoma Therapeutics Revenue Market Share by Region (2012-2017)

Figure United States Glaucoma Therapeutics Revenue Market Share by Region in 2016

Table United States Glaucoma Therapeutics Price (USD/Pcs) by Region (2012-2017)

Table United States Glaucoma Therapeutics Sales (K Pcs) by Type (2012-2017)

Table United States Glaucoma Therapeutics Sales Share by Type (2012-2017)

Figure United States Glaucoma Therapeutics Sales Share by Type (2012-2017)

Figure United States Glaucoma Therapeutics Sales Market Share by Type in 2016

Table United States Glaucoma Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Glaucoma Therapeutics Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Glaucoma Therapeutics by Type (2012-2017)

Figure Revenue Market Share of Glaucoma Therapeutics by Type in 2016

Table United States Glaucoma Therapeutics Price (USD/Pcs) by Types (2012-2017)

Figure United States Glaucoma Therapeutics Sales Growth Rate by Type (2012-2017)

Table United States Glaucoma Therapeutics Sales (K Pcs) by Application (2012-2017)

Table United States Glaucoma Therapeutics Sales Market Share by Application (2012-2017)

Figure United States Glaucoma Therapeutics Sales Market Share by Application (2012-2017)

Figure United States Glaucoma Therapeutics Sales Market Share by Application in 2016

Table United States Glaucoma Therapeutics Sales Growth Rate by Application (2012-2017)

Figure United States Glaucoma Therapeutics Sales Growth Rate by Application (2012-2017)

Table Allergan Basic Information List

Table Allergan Glaucoma Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Allergan Glaucoma Therapeutics Sales Growth Rate (2012-2017)

Figure Allergan Glaucoma Therapeutics Sales Market Share in United States (2012-2017)

Figure Allergan Glaucoma Therapeutics Revenue Market Share in United States (2012-2017)

Table Merck Basic Information List

Table Merck Glaucoma Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Merck Glaucoma Therapeutics Sales Growth Rate (2012-2017)

Figure Merck Glaucoma Therapeutics Sales Market Share in United States (2012-2017)

Figure Merck Glaucoma Therapeutics Revenue Market Share in United States (2012-2017)

Table Novartis Basic Information List

Table Novartis Glaucoma Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Novartis Glaucoma Therapeutics Sales Growth Rate (2012-2017)

Figure Novartis Glaucoma Therapeutics Sales Market Share in United States (2012-2017)

Figure Novartis Glaucoma Therapeutics Revenue Market Share in United States (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Glaucoma Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Pfizer Glaucoma Therapeutics Sales Growth Rate (2012-2017)

Figure Pfizer Glaucoma Therapeutics Sales Market Share in United States (2012-2017)

Figure Pfizer Glaucoma Therapeutics Revenue Market Share in United States (2012-2017)

Table Santen Pharmaceuticals Basic Information List

Table Santen Pharmaceuticals Glaucoma Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Santen Pharmaceuticals Glaucoma Therapeutics Sales Growth Rate (2012-2017)

Figure Santen Pharmaceuticals Glaucoma Therapeutics Sales Market Share in United States (2012-2017)

Figure Santen Pharmaceuticals Glaucoma Therapeutics Revenue Market Share in United States (2012-2017)

Table Valeant Pharmaceuticals Basic Information List

Table Valeant Pharmaceuticals Glaucoma Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Valeant Pharmaceuticals Glaucoma Therapeutics Sales Growth Rate (2012-2017)

Figure Valeant Pharmaceuticals Glaucoma Therapeutics Sales Market Share in United States (2012-2017)

Figure Valeant Pharmaceuticals Glaucoma Therapeutics Revenue Market Share in United States (2012-2017)

Table Aerie Pharmaceuticals Basic Information List

Table Aerie Pharmaceuticals Glaucoma Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Aerie Pharmaceuticals Glaucoma Therapeutics Sales Growth Rate (2012-2017)

Figure Aerie Pharmaceuticals Glaucoma Therapeutics Sales Market Share in United States (2012-2017)

Figure Aerie Pharmaceuticals Glaucoma Therapeutics Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Glaucoma Therapeutics

Figure Manufacturing Process Analysis of Glaucoma Therapeutics

Figure Glaucoma Therapeutics Industrial Chain Analysis

Table Raw Materials Sources of Glaucoma Therapeutics Major Players/Suppliers in 2016

Table Major Buyers of Glaucoma Therapeutics

Table Distributors/Traders List

Figure United States Glaucoma Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Glaucoma Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Glaucoma Therapeutics Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Glaucoma Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Glaucoma Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Glaucoma Therapeutics Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Glaucoma Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Glaucoma Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Glaucoma Therapeutics Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Glaucoma Therapeutics Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Glaucoma Therapeutics Sales Volume Share Forecast by Region (2017-2022)

Figure United States Glaucoma Therapeutics Sales Volume Share Forecast by Region (2017-2022)

Figure United States Glaucoma Therapeutics Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources